Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway

Abstract Yinchenhao decoction (YCHD), comprising Yinchenhao (Artemisiae Scopariae Herba), Zhizi (Gardeniae Fructus) and Dahuang (Radix Rhei et Rhizoma), is widely used for treating various diseases. We aimed to investigate the bile acid metabolic mechanism of YCHD in dimethylnitrosamine (DMN)-induce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fei-Fei Cai, Rong Wu, Ya-Nan Song, Ai-Zhen Xiong, Xiao-Le Chen, Meng-Die Yang, Li Yang, Yuanjia Hu, Ming-Yu Sun, Shi-Bing Su
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ef12ecebcbb74ec7bc6d968286ef2563
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ef12ecebcbb74ec7bc6d968286ef2563
record_format dspace
spelling oai:doaj.org-article:ef12ecebcbb74ec7bc6d968286ef25632021-12-02T15:08:52ZYinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway10.1038/s41598-018-33669-42045-2322https://doaj.org/article/ef12ecebcbb74ec7bc6d968286ef25632018-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-33669-4https://doaj.org/toc/2045-2322Abstract Yinchenhao decoction (YCHD), comprising Yinchenhao (Artemisiae Scopariae Herba), Zhizi (Gardeniae Fructus) and Dahuang (Radix Rhei et Rhizoma), is widely used for treating various diseases. We aimed to investigate the bile acid metabolic mechanism of YCHD in dimethylnitrosamine (DMN)-induced liver fibrosis model. Rats received DMN (10 mg/kg, intraperitoneally) for four successive weeks for liver fibrosis induction and were treated with YCHD for the last 2 weeks. Histopathological analysis showed that YCHD prevented DMN-induced histopathological changes in liver tissues. Serum liver function in YCHD group improved. Ultraperformance liquid chromatography-mass spectrometry analysis showed that YCHD significantly restored both free and conjugated bile acid levels increased by DMN, to normal levels. RT-qPCR results showed that YCHD treatment upregulated the expression of genes related to bile acid synthesis, reabsorption, and excretion. Western blotting analysis showed that YCHD downregulated α-SMA, TGF-β1, p-Smad3, and p-ERK1/2 expression in chenodeoxycholic acid (CDCA)-activated hepatic stellate cells (HSCs). The viability of CDCA-activated HSCs significantly increased after treatment with YCHD and PD98059 (an ERK inhibitor) compared to YCHD treatment alone. Our findings suggest that YCHD alleviated DMN-induced liver fibrosis by regulating enzymes responsible for bile acid metabolism. Additionally, it inhibits CDCA-induced HSC proliferation and activation via TGF-β1/Smad/ERK signalling pathway.Fei-Fei CaiRong WuYa-Nan SongAi-Zhen XiongXiao-Le ChenMeng-Die YangLi YangYuanjia HuMing-Yu SunShi-Bing SuNature PortfolioarticleToxic Bile AcidsYinchenhaoRegulates Bile Acid MetabolismHepatic Stellate Cells (HSC)Chenodeoxycholic Acid (CDCA)MedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Toxic Bile Acids
Yinchenhao
Regulates Bile Acid Metabolism
Hepatic Stellate Cells (HSC)
Chenodeoxycholic Acid (CDCA)
Medicine
R
Science
Q
spellingShingle Toxic Bile Acids
Yinchenhao
Regulates Bile Acid Metabolism
Hepatic Stellate Cells (HSC)
Chenodeoxycholic Acid (CDCA)
Medicine
R
Science
Q
Fei-Fei Cai
Rong Wu
Ya-Nan Song
Ai-Zhen Xiong
Xiao-Le Chen
Meng-Die Yang
Li Yang
Yuanjia Hu
Ming-Yu Sun
Shi-Bing Su
Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
description Abstract Yinchenhao decoction (YCHD), comprising Yinchenhao (Artemisiae Scopariae Herba), Zhizi (Gardeniae Fructus) and Dahuang (Radix Rhei et Rhizoma), is widely used for treating various diseases. We aimed to investigate the bile acid metabolic mechanism of YCHD in dimethylnitrosamine (DMN)-induced liver fibrosis model. Rats received DMN (10 mg/kg, intraperitoneally) for four successive weeks for liver fibrosis induction and were treated with YCHD for the last 2 weeks. Histopathological analysis showed that YCHD prevented DMN-induced histopathological changes in liver tissues. Serum liver function in YCHD group improved. Ultraperformance liquid chromatography-mass spectrometry analysis showed that YCHD significantly restored both free and conjugated bile acid levels increased by DMN, to normal levels. RT-qPCR results showed that YCHD treatment upregulated the expression of genes related to bile acid synthesis, reabsorption, and excretion. Western blotting analysis showed that YCHD downregulated α-SMA, TGF-β1, p-Smad3, and p-ERK1/2 expression in chenodeoxycholic acid (CDCA)-activated hepatic stellate cells (HSCs). The viability of CDCA-activated HSCs significantly increased after treatment with YCHD and PD98059 (an ERK inhibitor) compared to YCHD treatment alone. Our findings suggest that YCHD alleviated DMN-induced liver fibrosis by regulating enzymes responsible for bile acid metabolism. Additionally, it inhibits CDCA-induced HSC proliferation and activation via TGF-β1/Smad/ERK signalling pathway.
format article
author Fei-Fei Cai
Rong Wu
Ya-Nan Song
Ai-Zhen Xiong
Xiao-Le Chen
Meng-Die Yang
Li Yang
Yuanjia Hu
Ming-Yu Sun
Shi-Bing Su
author_facet Fei-Fei Cai
Rong Wu
Ya-Nan Song
Ai-Zhen Xiong
Xiao-Le Chen
Meng-Die Yang
Li Yang
Yuanjia Hu
Ming-Yu Sun
Shi-Bing Su
author_sort Fei-Fei Cai
title Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
title_short Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
title_full Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
title_fullStr Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
title_full_unstemmed Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
title_sort yinchenhao decoction alleviates liver fibrosis by regulating bile acid metabolism and tgf-β/smad/erk signalling pathway
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/ef12ecebcbb74ec7bc6d968286ef2563
work_keys_str_mv AT feifeicai yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT rongwu yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT yanansong yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT aizhenxiong yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT xiaolechen yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT mengdieyang yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT liyang yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT yuanjiahu yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT mingyusun yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
AT shibingsu yinchenhaodecoctionalleviatesliverfibrosisbyregulatingbileacidmetabolismandtgfbsmaderksignallingpathway
_version_ 1718388035608903680